Michelson Diagnostics appoints Xavier Yon as Non Executive Director

We are pleased to report that Xavier Yon has joined the Board of Michelson Diagnostics Ltd as a Non Executive Director.  Xavier has spent more than 40 years in the medical industry, of which 15 years were spent as CEO of the major dermatology company Galderma (a joint venture of L’Oreal and Nestle).  During his time at Galderma he built the company from its initial spin out from Alcon to be a world leader in ethical dermatology.  Previous roles in his career include senior business executive positions with Pfizer, Solvay and Alcon.

Since his retirement from Galderma, Xavier has embarked on his own consultancy activities.  These have included managing a group of aesthetic centres in Paris for a VC, advising smaller dermatology companies and helping with medtech and dermatology product launches.

Xavier says: “Since my tenure with Galderma, I have always been attracted by new technologies in the field of dermatology, those which offer real value addition to the practitioners and their patients.  VivoSight [Michelson Diagnostics’ CE approved and FDA cleared Optical Coherence Tomography scanner] is definitely a unique device that falls into that category of breakthrough technology.  Together with the Michelson Diagnostics Team, I intend to help making VivoSight available to clinicians in selected EU countries and in the US”.